​Help monitor COVID-19 patients at home with pulse oximeters

December 3, 2020

Pulse oximeters – the small electronic devices used to measure heart rate and oxygen saturation in a patient's red blood cells – are a useful tool to monitor COVID-19 at home.

AmeriHealth covers the device for patients under evaluation for or with a confirmed COVID-19 diagnosis to use at home. We have waived member cost-share* (i.e., copayment, deductible, and coinsurance) and referral requirements for this device through March 31, 2021, when supplied by one of our dedicated participating pulse oximetry providers.

If a patient satisfies the clinical coverage criteria in a facility, the discharging physician should provide a prescription to the member with the contact information for one of our dedicated durable medical equipment (DME) suppliers. The member – or medical personnel on behalf of the member – should call the DME supplier directly to arrange home delivery of the pulse oximeter.

The AmeriHealth dedicated participating DME suppliers are:

  • Apria (Phone: 1-855-709-9966; Fax: 1-888-492-0010)
  • Better Living Now (1-877-290-5186)
  • Complete Medical Supplies (1-866-748-5151)
  • Montgomery Medical (610-630-6357)
  • Specialty Medical Products (610-644-1370)

For information about clinical coverage criteria and coding, please read COVID-19 (Coronavirus): Coverage for respiratory equipment and related supplies.

*Self-funded customers can choose to opt out of the cost-share waiver.​

Member cost-sharing is waived both in an out-of-network for the testing and diagnosis of COVID-19 through the public health emergency. The waiver of cost-sharing for out-of-network testing and diagnosis of COVID-19 will continue until 90 days after the end of both the state of emergency and public health emergency declared by the state of New Jersey. For High Deductible Health Plans, in-network cost-sharing waivers will remain in effect through December 31, 2020, unless prohibited by law.​